Payment overview · 2025
General Payments
$191.15
7 reported records · 1 companies
Healthcare provider profile · identity verified
Ryan James Mikac, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · AMHERST, NY · NPI 1346502689
Verified facts
What the public records show
CMS Open Payments records show Ryan James Mikac, D.O. received $191.15 in general payments during 2025 across 7 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Austedo Xr.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 44 claims for Austedo Xr by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $191.15 | 100.0% | 7 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $191.15 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $191.15 | 7 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AUSTEDO XR austedo xr |
2025 | Austedo Xr | 2024 | 44 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
44 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 1161 | 152 |
| Eliquis | Apixaban | 1076 | 113 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1068 | 168 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1028 | 126 |
| Metoprolol Succinate | Metoprolol Succinate | 953 | 122 |
| Amlodipine Besylate | Amlodipine Besylate | 874 | 127 |
| Gabapentin | Gabapentin | 795 | 123 |
| Metformin Hcl | Metformin Hcl | 654 | 66 |
| Sertraline Hcl | Sertraline Hcl | 521 | 71 |
| Furosemide | Furosemide | 507 | 85 |
| Tamsulosin Hcl | Tamsulosin Hcl | 497 | 79 |
| Mirtazapine | Mirtazapine | 473 | 84 |
| Lisinopril | Lisinopril | 456 | 71 |
| Escitalopram Oxalate | Escitalopram Oxalate | 451 | 62 |
| Potassium Chloride | Potassium Chloride | 438 | 54 |
| Trazodone Hcl | Trazodone Hcl | 400 | 51 |
| Omeprazole | Omeprazole | 316 | 34 |
| Divalproex Sodium | Divalproex Sodium | 310 | 34 |
| Donepezil Hcl | Donepezil Hcl | 310 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 310 | 54 |
| Bumetanide | Bumetanide | 299 | 47 |
| Famotidine | Famotidine | 295 | 35 |
| Levetiracetam | Levetiracetam | 295 | 45 |
| Jardiance | Empagliflozin | 292 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 282 | 48 |
| Carvedilol | Carvedilol | 277 | 48 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 274 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 271 | 43 |
| Losartan Potassium | Losartan Potassium | 254 | 26 |
| Xarelto | Rivaroxaban | 241 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 223 | 55 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 219 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 212 | 22 |
| Myrbetriq | Mirabegron | 212 | 18 |
| Baclofen | Baclofen | 202 | 20 |
| Midodrine Hcl | Midodrine Hcl | 193 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 189 | 39 |
| Hydralazine Hcl | Hydralazine Hcl | 188 | 32 |
| Memantine Hcl | Memantine Hcl | 185 | 25 |
| Buspirone Hcl | Buspirone Hcl | 159 | 29 |
| Aripiprazole | Aripiprazole | 156 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 154 | 16 |
| Trulicity | Dulaglutide | 154 | 29 |
| Simvastatin | Simvastatin | 151 | 15 |
| Latanoprost | Latanoprost | 148 | 31 |
| Metformin Hcl Er | Metformin Hcl | 136 | 37 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 125 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 122 | 20 |
| Risperidone | Risperidone | 118 | 19 |
| Celecoxib | Celecoxib | 115 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 115 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 115 | suppressed |
| Folic Acid | Folic Acid | 114 | 12 |
| Finasteride | Finasteride | 113 | 22 |
| Diltiazem Hcl | Diltiazem Hcl | 110 | suppressed |
| Januvia | Sitagliptin Phosphate | 109 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 16 |
| Spironolactone | Spironolactone | 105 | 24 |
| Valsartan | Valsartan | 105 | 12 |
| Lamotrigine | Lamotrigine | 98 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 98 | suppressed |
| Lovastatin | Lovastatin | 94 | suppressed |
| Prednisone | Prednisone | 89 | 32 |
| Olanzapine | Olanzapine | 82 | 14 |
| Ingrezza | Valbenazine Tosylate | 81 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 80 | 44 |
| Irbesartan | Irbesartan | 80 | 13 |
| Lactulose | Lactulose | 75 | 20 |
| Glipizide | Glipizide | 72 | 11 |
| Metoclopramide Hcl | Metoclopramide Hcl | 71 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 70 | 20 |
| Bupropion Xl | Bupropion Hcl | 69 | 11 |
| Meloxicam | Meloxicam | 68 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 67 | 42 |
| Cephalexin | Cephalexin | 67 | 23 |
| Nifedipine Er | Nifedipine | 61 | suppressed |
| Nystatin | Nystatin | 61 | 27 |
| Brimonidine Tartrate | Brimonidine Tartrate | 60 | 11 |
| Alendronate Sodium | Alendronate Sodium | 58 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 58 | 13 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 58 | 27 |
| Gemfibrozil | Gemfibrozil | 55 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 55 | suppressed |
| Calcium Acetate | Calcium Acetate | 54 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 54 | 39 |
| Doxycycline Hyclate | Doxycycline Hyclate | 52 | 21 |
| Prazosin Hcl | Prazosin Hcl | 51 | suppressed |
| Enulose | Lactulose | 50 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 50 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 50 | 15 |
| Lansoprazole | Lansoprazole | 50 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 50 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 49 | 14 |
| Gemtesa | Vibegron | 48 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 48 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 46 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 46 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 46 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 45 | suppressed |
| Invokana | Canagliflozin | 45 | suppressed |
| Austedo Xr | Deutetrabenazine | 44 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 44 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 44 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | suppressed |
| Ezetimibe | Ezetimibe | 43 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 43 | 29 |
| Incruse Ellipta | Umeclidinium Bromide | 43 | 12 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 43 | 17 |
| Rasagiline Mesylate | Rasagiline Mesylate | 43 | suppressed |
| Synthroid | Levothyroxine Sodium | 43 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | 13 |
| Glipizide Er | Glipizide | 41 | suppressed |
| Methazolamide | Methazolamide | 41 | suppressed |
| Sucralfate | Sucralfate | 41 | suppressed |
| Zonisamide | Zonisamide | 41 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 18 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 40 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 39 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 12 |
| Entresto | Sacubitril/Valsartan | 39 | suppressed |
| Anagrelide Hcl | Anagrelide Hcl | 38 | suppressed |
| Felodipine Er | Felodipine | 37 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 37 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 36 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 36 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 36 | suppressed |
| Ramelteon | Ramelteon | 36 | 15 |
| Santyl | Collagenase Clostridium Hist. | 36 | 26 |
| Topiramate | Topiramate | 35 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 34 | 20 |
| Clonidine Hcl | Clonidine Hcl | 33 | suppressed |
| Letrozole | Letrozole | 33 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 33 | suppressed |
| Cyclosporine | Cyclosporine | 32 | suppressed |
| Insulin Lispro | Insulin Lispro | 31 | 12 |
| Lorazepam | Lorazepam | 31 | 19 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 30 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 30 | 26 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 30 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 30 | 11 |
| Tramadol Hcl | Tramadol Hcl | 30 | 24 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 29 | 28 |
| Dexamethasone | Dexamethasone | 28 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Haloperidol | Haloperidol | 28 | suppressed |
| Pentoxifylline | Pentoxifylline | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Timolol Maleate | Timolol Maleate | 27 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 26 | suppressed |
| Ozempic | Semaglutide | 26 | suppressed |
| Rexulti | Brexpiprazole | 26 | suppressed |
| Alprazolam | Alprazolam | 25 | 14 |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Clonazepam | Clonazepam | 25 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 25 | suppressed |
| Entacapone | Entacapone | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 25 | suppressed |
| Trospium Chloride Er | Trospium Chloride | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 18 |
| Galantamine Er | Galantamine Hbr | 24 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 24 | suppressed |
| Linzess | Linaclotide | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 24 | suppressed |
| Carbamazepine | Carbamazepine | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Ibuprofen | Ibuprofen | 22 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 22 | suppressed |
| Paliperidone Er | Paliperidone | 22 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 21 | 13 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 21 | suppressed |
| Azithromycin | Azithromycin | 21 | 17 |
| Perphenazine | Perphenazine | 21 | suppressed |
| Renacidin | Citric Ac/Gluconolact/Mag Carb | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 14 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 20 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 20 | 14 |
| Amantadine | Amantadine Hcl | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | 16 |
| Hydrocortisone | Hydrocortisone | 19 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 19 | suppressed |
| Trospium Chloride | Trospium Chloride | 19 | suppressed |
| Securesafe Pen Needle | Pen Needle, Diabetic, Safety | 18 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 18 | 12 |
| Amoxicillin | Amoxicillin | 17 | 15 |
| Atenolol | Atenolol | 17 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Calcitriol | Calcitriol | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 15 |
| Sulfasalazine Dr | Sulfasalazine | 17 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 17 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 16 | suppressed |
| Cholestyramine Light | Cholestyramine | 16 | suppressed |
| Dulera | Mometasone/Formoterol | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Nystop | Nystatin | 16 | 13 |
| Sevelamer Hcl | Sevelamer Hcl | 16 | suppressed |
| Metronidazole | Metronidazole | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 15 | 12 |
| Primidone | Primidone | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Allopurinol | Allopurinol | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Lumigan | Bimatoprost | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Acetic Acid | Acetic Acid | 11 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nadolol | Nadolol | 11 | suppressed |
| Olanzapine Odt | Olanzapine | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $191.15 · 7 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Austedo Xr play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Teva Pharmaceuticals USA, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error